Use of 4-(2-fluorophenyl)-6-methyl-2-(1-pipera zinyl)thieno(2, 3-d)-pyrimidine for treating of urinary incontinence

Details for Australian Patent Application No. 2003205836 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): 0202265.5 31.01.02 GB

18 September 2003 Application Open to Public Inspection

Published as AU-B-2003205836

29 June 2006 Application Accepted

Published as AU-B-2003205836

19 October 2006 Opposition Lodged

Dynogen Pharmaceuticals, Inc. has lodged an opposition against Arachnova Therapeutics Ltd.

10 January 2008 Opposition Withdrawn

The opposition by Dynogen Pharmaceuticals, Inc. against Arachnova Therapeutics Ltd has been withdrawn.

14 February 2008 Assignment before Grant

Arachnova Therapeutics Ltd. The application has been assigned to Dynogen Pharmaceuticals, Inc.

21 February 2008 Standard Patent Sealed

26 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.